TipRanks
Zimmer Biomet Holdings (ZBH)
NYSE:ZBH
US Market
ZBH
Zimmer Biomet Holdings
RESEARCH TOOLSreports
Want to see ZBH full AI Analyst Report?

Zimmer Biomet Holdings (ZBH) Stock Forecast & Price Target

1,105 Followers
See the Price Targets and Ratings of:

ZBH Analyst Ratings

Moderate Buy
19Ratings
Moderate Buy
5 Buy
14 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Zimmer
Biomet Holdings
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ZBH Stock 12 Month Forecast

Average Price Target

$104.88
▲(4.62% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Zimmer Biomet Holdings in the last 3 months. The average price target is $104.88 with a high forecast of $120.00 and a low forecast of $93.00. The average price target represents a 4.62% change from the last price of $100.24.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"81":"$81","91":"$91","101":"$101","111":"$111","121":"$121"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":120,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$120.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":104.875,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$104.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":93,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$93.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[81,91,101,111,121],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,88.06,90.51692307692308,92.97384615384615,95.43076923076923,97.8876923076923,100.34461538461538,102.80153846153846,105.25846153846155,107.71538461538461,110.1723076923077,112.62923076923076,115.08615384615385,117.54307692307692,{"y":120,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,88.06,89.35346153846154,90.64692307692307,91.94038461538462,93.23384615384616,94.52730769230769,95.82076923076923,97.11423076923077,98.40769230769232,99.70115384615384,100.99461538461539,102.28807692307691,103.58153846153846,{"y":104.875,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,88.06,88.44,88.82000000000001,89.2,89.58,89.96000000000001,90.34,90.72,91.1,91.48,91.86,92.24,92.62,{"y":93,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":97.842,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.494,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.756,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":89.203,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":85.533,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.697,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":90.55,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.463,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.502,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":83.948,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.683,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":99.138,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.06,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$120.00Average Price Target$104.88Lowest Price Target$93.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on ZBH
Mike Kratky
Leerink Partners
Leerink Partners
$106→$97
Hold
-3.23%
Downside
Assigned
10/12/26
Leerink Partners Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH)
BTIG Analyst forecast on ZBH
Gray Powell
BTIG
BTIG
―
Hold
―
Reiterated
10/09/26
Analysts' Top Healthcare Picks: Cytek Biosciences (CTKB), Zimmer Biomet Holdings (ZBH)
Barclays Analyst forecast on ZBH
Christopher Pasquale
Barclays
Barclays
$100
Hold
-0.24%
Downside
Initiated
10/07/26
Zimmer Biomet Holdings (ZBH) Receives a Hold from Barclays
Citi Analyst forecast on ZBH
Joanne Wuensch
Citi
Citi
$99
Hold
-1.24%
Downside
Reiterated
10/05/26
Citi opens 'upside 90-day catalyst watch' on Zimmer BiometCiti opens 'upside 90-day catalyst watch' on Zimmer Biomet
RBC Capital Analyst forecast on ZBH
Kendall Au
RBC Capital
RBC Capital
$110
Buy
9.74%
Upside
Reiterated
10/01/26
RBC Capital Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH)
Bank of America Securities Analyst forecast on ZBH
Travis Steed
Bank of America Securities
Bank of America Securities
$110
Hold
9.74%
Upside
Reiterated
09/25/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (NASDAQ: ARCT), Teladoc (NYSE: TDOC) and Zimmer Biomet Holdings (NYSE: ZBH)
Truist Financial Analyst forecast on ZBH
Richard Newitter
Truist Financial
Truist Financial
$106
Hold
5.75%
Upside
Reiterated
09/16/26
Truist Financial Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)
J.P. Morgan Analyst forecast on ZBH
Robbie Marcus
J.P. Morgan
J.P. Morgan
$117
Hold
16.72%
Upside
Reiterated
08/17/26
J.P. Morgan Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)
Canaccord Genuity Analyst forecast on ZBH
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
$83→$100
Buy
-0.24%
Downside
Reiterated
08/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
William Blair Analyst forecast on ZBH
Steven Lichtman
William Blair
William Blair
―
Hold
―
Reiterated
08/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Enliven Therapeutics (NASDAQ: ELVN) and Encompass Health (NYSE: EHC)
Deutsche Bank Analyst forecast on ZBH
Pito Chickering
Deutsche Bank
Deutsche Bank
$88→$98
Hold
-2.23%
Downside
Reiterated
08/06/26
Deutsche Bank Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)
Robert W. Baird Analyst forecast on ZBH
Jeff Johnson
Robert W. Baird
Robert W. Baird
$92→$104
Hold
3.75%
Upside
Reiterated
08/06/26
Zimmer Biomet price target raised to $104 from $92 at BairdZimmer Biomet price target raised to $104 from $92 at Baird
Wells Fargo Analyst forecast on ZBH
Larry Biegelsen
Wells Fargo
Wells Fargo
$90→$103
Hold
2.75%
Upside
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Cytek Biosciences (NASDAQ: CTKB) and Sight Sciences (NASDAQ: SGHT)
BMO Capital Analyst forecast on ZBH
Vik Chopra
BMO Capital
BMO Capital
$95→$96
Hold
-4.23%
Downside
Reiterated
08/06/26
Zimmer Biomet price target raised to $96 from $95 at BMO CapitalZimmer Biomet price target raised to $96 from $95 at BMO Capital
Stifel Nicolaus Analyst forecast on ZBH
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$105→$110
Buy
9.74%
Upside
Assigned
08/06/26
Zimmer Biomet Holdings (ZBH) Receives a Buy from Stifel Nicolaus
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Leerink Partners Analyst forecast on ZBH
Mike Kratky
Leerink Partners
Leerink Partners
$106→$97
Hold
-3.23%
Downside
Assigned
10/12/26
Leerink Partners Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH)
BTIG Analyst forecast on ZBH
Gray Powell
BTIG
BTIG
―
Hold
―
Reiterated
10/09/26
Analysts' Top Healthcare Picks: Cytek Biosciences (CTKB), Zimmer Biomet Holdings (ZBH)
Barclays Analyst forecast on ZBH
Christopher Pasquale
Barclays
Barclays
$100
Hold
-0.24%
Downside
Initiated
10/07/26
Zimmer Biomet Holdings (ZBH) Receives a Hold from Barclays
Citi Analyst forecast on ZBH
Joanne Wuensch
Citi
Citi
$99
Hold
-1.24%
Downside
Reiterated
10/05/26
Citi opens 'upside 90-day catalyst watch' on Zimmer BiometCiti opens 'upside 90-day catalyst watch' on Zimmer Biomet
RBC Capital Analyst forecast on ZBH
Kendall Au
RBC Capital
RBC Capital
$110
Buy
9.74%
Upside
Reiterated
10/01/26
RBC Capital Reaffirms Their Buy Rating on Zimmer Biomet Holdings (ZBH)
Bank of America Securities Analyst forecast on ZBH
Travis Steed
Bank of America Securities
Bank of America Securities
$110
Hold
9.74%
Upside
Reiterated
09/25/26
Analysts' Opinions Are Mixed on These Healthcare Stocks: Arcturus Therapeutics (NASDAQ: ARCT), Teladoc (NYSE: TDOC) and Zimmer Biomet Holdings (NYSE: ZBH)
Truist Financial Analyst forecast on ZBH
Richard Newitter
Truist Financial
Truist Financial
$106
Hold
5.75%
Upside
Reiterated
09/16/26
Truist Financial Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)
J.P. Morgan Analyst forecast on ZBH
Robbie Marcus
J.P. Morgan
J.P. Morgan
$117
Hold
16.72%
Upside
Reiterated
08/17/26
J.P. Morgan Sticks to Its Hold Rating for Zimmer Biomet Holdings (ZBH)
Canaccord Genuity Analyst forecast on ZBH
Caitlin Roberts
Canaccord Genuity
Canaccord Genuity
$83→$100
Buy
-0.24%
Downside
Reiterated
08/10/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
William Blair Analyst forecast on ZBH
Steven Lichtman
William Blair
William Blair
―
Hold
―
Reiterated
08/06/26
Analysts Have Conflicting Sentiments on These Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Enliven Therapeutics (NASDAQ: ELVN) and Encompass Health (NYSE: EHC)
Deutsche Bank Analyst forecast on ZBH
Pito Chickering
Deutsche Bank
Deutsche Bank
$88→$98
Hold
-2.23%
Downside
Reiterated
08/06/26
Deutsche Bank Reaffirms Their Hold Rating on Zimmer Biomet Holdings (ZBH)
Robert W. Baird Analyst forecast on ZBH
Jeff Johnson
Robert W. Baird
Robert W. Baird
$92→$104
Hold
3.75%
Upside
Reiterated
08/06/26
Zimmer Biomet price target raised to $104 from $92 at BairdZimmer Biomet price target raised to $104 from $92 at Baird
Wells Fargo Analyst forecast on ZBH
Larry Biegelsen
Wells Fargo
Wells Fargo
$90→$103
Hold
2.75%
Upside
Assigned
08/06/26
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH), Cytek Biosciences (NASDAQ: CTKB) and Sight Sciences (NASDAQ: SGHT)
BMO Capital Analyst forecast on ZBH
Vik Chopra
BMO Capital
BMO Capital
$95→$96
Hold
-4.23%
Downside
Reiterated
08/06/26
Zimmer Biomet price target raised to $96 from $95 at BMO CapitalZimmer Biomet price target raised to $96 from $95 at BMO Capital
Stifel Nicolaus Analyst forecast on ZBH
Rick Wise
Stifel Nicolaus
Stifel Nicolaus
$105→$110
Buy
9.74%
Upside
Assigned
08/06/26
Zimmer Biomet Holdings (ZBH) Receives a Buy from Stifel Nicolaus
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
REPLReplimune Group
OVIDOvid Therapeutics
IMUXImmunic
PTGXProtagonist Therapeutics
ESTAEstablishment Labs Holdings
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zimmer Biomet Holdings

3 Months
Rick WiseStifel Nicolaus
Success Rate
14/29 ratings generated profit
48%
Average Return
+1.29%
Copying Rick Wise's trades and holding each position for 3 Months would result in 48.28% of your transactions generating a profit, with an average return of +1.29% per trade.
1 Year
Rick WiseStifel Nicolaus
Success Rate
13/29 ratings generated profit
45%
Average Return
+3.32%
Copying Rick Wise's trades and holding each position for 1 Year would result in 44.83% of your transactions generating a profit, with an average return of +3.32% per trade.
2 Years
Rick WiseStifel Nicolaus
Success Rate
9/29 ratings generated profit
31%
Average Return
-5.83%
Copying Rick Wise's trades and holding each position for 2 Years would result in 31.03% of your transactions generating a profit, with an average return of -5.83% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZBH Analyst Recommendation Trends

Rating
Jun 26
Jul 26
Aug 26
Sep 26
Oct 26
Strong Buy
0
0
0
0
0
Buy
6
5
10
9
6
Hold
17
10
22
22
22
Sell
1
0
0
0
0
Strong Sell
0
0
0
0
0
total
24
15
32
31
28
In the current month, ZBH has received 6 Buy Ratings, 22 Hold Ratings, and 0 Sell Ratings. ZBH average Analyst price target in the past 3 months is 104.88.
Each month's total comprises the sum of three months' worth of ratings.

ZBH Financial Forecast

ZBH Earnings Forecast

Next quarter’s earnings estimate for ZBH is $1.88 with a range of $1.86 to $1.91. The previous quarter’s EPS was $2.07. ZBH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.
Next quarter’s earnings estimate for ZBH is $1.88 with a range of $1.86 to $1.91. The previous quarter’s EPS was $2.07. ZBH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.

ZBH Sales Forecast

Next quarter’s sales forecast for ZBH is $2.04B with a range of $2.03B to $2.05B. The previous quarter’s sales results were $2.18B. ZBH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.
Next quarter’s sales forecast for ZBH is $2.04B with a range of $2.03B to $2.05B. The previous quarter’s sales results were $2.18B. ZBH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year ZBH has Performed in-line its overall industry.

ZBH Stock Forecast FAQ

What is ZBH’s average 12-month price target, according to analysts?
Based on analyst ratings, Zimmer Biomet Holdings’s 12-month average price target is 104.88.
    What is ZBH’s upside potential, based on the analysts’ average price target?
    Zimmer Biomet Holdings has 4.62% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ZBH a Buy, Sell or Hold?
          Zimmer Biomet Holdings has a consensus rating of Moderate Buy which is based on 5 buy ratings, 14 hold ratings and 0 sell ratings.
            What is Zimmer Biomet Holdings’s price target?
            The average price target for Zimmer Biomet Holdings is 104.88. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $120.00 ,the lowest forecast is $93.00. The average price target represents 4.62% Increase from the current price of $100.24.
              What do analysts say about Zimmer Biomet Holdings?
              Zimmer Biomet Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.
                How can I buy shares of ZBH?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.